Designating one specialist to screen and manage osteoporosis can improve outcomes
Bone strength is an important consideration for aging Americans, many of whom buy Actonel from a Canadian internet pharmacy to reduce their risk of experiencing osteoporosis.
Bone strength is an important consideration for aging Americans, many of whom buy Actonel from a Canadian internet pharmacy to reduce their risk of experiencing osteoporosis. According to a new study from St. Michael's Hospital, more patients receive appropriate screening and treatment for this disease at fracture clinics that have a professional whose sole responsibility is to address this illness.
Lead investigator Joanne Sale and her colleagues published their findings in the journal Osteoporosis International. They evaluated osteoporosis screening and management techniques and programs at fracture clinics in 11 different countries.
According to the researchers, such a facility tends to be very busy. Since orthopedic surgeons, residents, physiotherapists and technicians have many demands for their time, designating one individual to identify patients at risk for osteoporosis can help improve outcomes.
"Outcomes are also better when the test or treatment takes place within the program, rather than sending the patient elsewhere and potentially losing contact with them," Sale explained.
An estimated 2 million Canadians suffer from the bone disease, which occurs in about one in four women over the age of 50.
|
